株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ナノバイオテクノロジーの世界市場

Nanobiotechnology

発行 Global Industry Analysts, Inc. 商品コード 236769
出版日 ページ情報 英文 267 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.47円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
ナノバイオテクノロジーの世界市場 Nanobiotechnology
出版日: 2017年01月01日 ページ情報: 英文 267 Pages
概要

当レポートでは、世界のナノバイオテクノロジーの市場を調査し、産業の定義と概要、最新の動向と市場成長への各種影響因子の分析、競合環境、技術的発展、関連法規制、地域による取り組み、製品の開発・発売などの動向、企業および企業間の取り組み、主要企業のプロファイル、世界および主要地域・国別の市場動向と市場規模の推移と予測などをまとめています。

第1部 イントロダクション・調査手法・製品の定義

第2部 エグゼクティブサマリー

第1章 産業概要

  • 世界のナノバイオテクノロジー市場:分析
  • 主要市場成長推進因子
  • ナノテクノロジーによる医薬品・ヘルスケア部門の革新
  • ナノメディシン市場の大幅成長
  • ナノメディシンの市場機会
  • ドラッグデリバリー:ナノテクノロジーの確実な分野
  • ナノテクノロジー:脳障害治療における大きな可能性
  • 高需要のナノボット・ナノヘルスケアデバイス
  • ナノテクノロジー:がん治療における重要性の拡大
  • ドラッグデリバリーにおけるナノテクノロジー:特別な市場機会
  • 勢いづくナノテクノロジーベースの医療製品の製品化
  • ナノ診断製品需要の大幅な拡大、など

第2章 競合シナリオ

  • 主要部門における競合
  • ナノ粒子
  • ナノチューブとフラーレン
  • デンドリマー
  • 中小規模企業により製品開発
  • 主な承認済みナノテクノロジードラッグデリバリーデバイスのリスト
  • 主要ナノスケールドラッグデリバリーデバイスの状況
  • ナノメディシン領域における協力の拡大、など

第3章 市場力学

  • 現在の状況と将来の市場機会
  • 新興諸国の台頭
  • ナノマテリアル・ナノ粒子分野の活発化
  • ナノバイオテクノロジーへの投資の合理性
  • 官民によるナノテクノロジー分野への投資の拡大
  • 米国:政府による投資をリード
  • 技術への認知度の拡大が成長を推進
  • 新製品への需要
  • ナノ技術による創薬の大きな可能性
  • 技術による法規制の枠組みの進化
  • 量子ドット関連特許、など

第4章 産業における課題

  • 商業化への模索
  • 従来型医薬品の抵抗
  • ナノテクノロジーによる診断・治療の複雑性
  • ナノマテリアル利用:毒性上の懸念
  • 製造における課題
  • 倫理性
  • 社会的重要性
  • 経済的重要性、など

第5章 産業構造

  • 法規制の枠組み
  • 地域による取り組み、など

第6章 ナノバイオテクノロジーの画期的躍進

  • 概要
  • ドラッグデリバリーシステムへの影響
  • メリット
  • 分子診断画像への影響
  • 治療への影響
  • 効果的な抗菌剤としてのシルバーナノ粒子
  • 現代のナノメディシン:現在のシナリオ
  • ナノテクノロジー診断
  • ナノバイオテクノロジー技術の癌への影響:ケーススタディ
  • 将来の用途
  • バイオ分子モーター
  • 遺伝子工学・組織工学
  • LOC (Laboratory-on-chip):ポータブル診断ラボ
  • 医療診断センサー
  • ナノ医療機器:手術用ツールからコンタクトレンズまで
  • ナノ工学補綴
  • ナノチューブ:潜在的なドラッグデリバリーの推進因子、など

第7章 製品の開発・発売

  • A*STAR:癌治療のためのナノサイズ分子を開発
  • MIT:癌治療薬耐性の戦うナノデバイスを開発、など

第8章 概念的概要

  • ナノテクノロジー:イントロダクション
  • ナノバイオテクノロジーと医薬品
  • ナノバイオテクノロジーとバイオ燃料
  • 主要技術区分の分析
  • ナノマテリアル
  • ナノデバイス
  • ナノツール
  • 疾患治療向けナノテクノロジー
  • パーキンソン病
  • アルツハイマー病
  • 結核
  • 歯科
  • 眼科
  • 手術

第9章 世界の研究センター・機関

  • Cornell's Nanobiotechnology Center (米国)
  • Institute of Bioengineering and Nanotechnology (シンガポール)
  • Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) (米国)
  • The Tyndall National Institute (アイルランド)

第10章 近年の業界の動き

  • Vectura Group:Skyepharmaとの合併合意に署名
  • Flamel Technologies:Avadel Pharmaceuticalsとの合併予定
  • Pfizer:BIND Therapeutics資産を取得予定、など

第11章 世界の主要企業

  • Ablynx NV (ベルギー)
  • Arrowhead Pharmaceuticals, Inc. (米国)
  • Avadel Pharmaceuticals plc (アイルランド)
  • CaPtivate Pharmaceuticals LLC (米国)
  • Celgene Corporation (米国)
  • ELITechGroup (フランス)
  • GlaxoSmithKline Plc. (英国)
  • Johnson & Johnson (米国)
  • Merck & Co., Inc. (米国)
  • NanoBio® Corporation (米国)
  • Nanophase Technologies Corporation (米国)
  • pSivida Corp. (米国)
  • Sigma-Aldrich Corp. (米国)
  • Starpharma Holdings Ltd. (オーストラリア)
  • Vectura Group plc (英国)

第12章 世界市場の展望

第3部 市場分析

  • 米国
  • 日本
  • 欧州
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-1476

This report analyzes the worldwide markets for Nanobiotechnology in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

Ablynx NV
Arrowhead Pharmaceuticals, Inc.
Avadel Pharmaceuticals plc
CaPtivate Pharmaceuticals LLC
Celgene Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Curtain Raiser
  • Nanobiotechnology - The Next Big Thing
  • An Insight into the Global Nanobiotechnology Market
  • Major Market Drivers
  • Where Conventional Molecular Science Falls Short...Nanobio Steps In
  • Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
  • Nanomedicine Market to Achieve Phenomenal Growth
  • Opportunities Galore for Nanomedicine
  • Drug Delivery - A Promising Application Area for Nanotechnology
    • Benefits Offered by Nanostructures in Drug Delivery
    • Select Key Requirements for Development of Advanced Drug Delivery Systems
  • Nanotechnology Offers Huge Potential in Brain Disorder Treatment
  • High Demand for Nanobots and Nano Healthcare Devices
  • Nanotechnology Gaining Prominence for Treatment of Cancer
  • Nanotechnology in Drug Delivery: A Specialized Market Opportunity
  • Commercialization of Nanotechnology-based Medical Products Gains Momentum
  • Nanodiagnostic Products to Witness Strong Demand Growth
  • Dendrimers Serve as a Base to Build Multifunctional Nanodevices
  • Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
  • Huge Opportunities for Nanomaterials in the Medical Field
  • Commercial Opportunities in Healthcare Sector
  • Future Possibilities
  • Global Market for Fullerenes - An Insight
  • Dawn Breaks on Nanobiotechnology
  • Demystifying the Intriguing World of Nanobiotech
  • A Meeting Place of Medicine's Best Solutions
  • Nanobiotechnology to Become Viable for All Drug Development Stages
  • Nanoparticles: The Foundation of Nanobiotechnology
  • Improved Optical Properties and Stability of Nanoparticles
  • Nanoemulsions
  • The Promise of Nanobiotechnology
  • Biological Weaponries against Diseases Come in Small Packages
  • Proffered Benefits of Nanobiotechnology
  • Opportunity & Beyond
  • Nanobiotechnology - Will it Live Up to the Expectations?
  • The Future of Nanobiotechnology: Shape of Things to Come
  • Nanobiotechnology: The Outer Limits
  • Futuristics: A Rumination
  • Conclusions

2. COMPETITIVE SCENARIO

  • Competition in Select Segments
  • Nanoparticles
  • Nanotubes and Fullerenes
  • Dendrimers
  • Small and Medium-Sized Enterprises Spearheading Product Development
  • List of Select Approved Nanotechnology-based Drug Delivery Devices
  • Status of Select Nanoscale Drug Delivery Devices
  • Collaborations Activity Picking Up Pace in Nanomedicine Domain

3. MARKET DYNAMICS

  • Present Status and Future Opportunities
  • Outlook
  • Developing Countries to Rise over the Horizon
  • Nanomaterials & Nanoparticles Witness Robust Activity
  • Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
  • Why Invest in Nanobiotechnology?
  • Private and Public Companies to Step Up Funding on Nanotechnology
  • United States Lead the Way in Government Funding
  • Increasing Awareness on Technology to Drive Growth
  • Demand for Novel Products to Push Up Growth
  • Nano-Enabled Drug Discovery Holds Tremendous Potential
  • Consolidation Sharpens the Industry's Edge
  • The Regulatory Framework Evolves with the Technology
    • Nanobiotechnology Gathers a Miniscule Share in Biotechnology Patents
    • Table 1: Percentage Breakdown of Number of Nanotechnology Publications in USPTO & EPO by Region/Country (2016) (includes corresponding Graph/Chart)
  • Quantum Dot Patents Pose Legal Tangles
  • Miniaturized Liquid Handling Becomes Progressive
  • Trends in Nanotechnology Enabled Drug Delivery Systems
    • Robust Growth on the Cards
    • Table 2: Global Nanomedicine Market by Application (2015): Percentage Breakdown of the Market for Drug Delivery, Implants, In vivo Diagnostics and In vitro Diagnostics (includes corresponding Graph/Chart)
  • Patent Expiries: A Key Driver
  • Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs

4. INDUSTRY CHALLENGES & ISSUES

  • Challenges
  • Commercial Exploration: A Treacherous Voyage
  • Conventional Medicine to Contest Nanomedicine Adoption
  • Complexity of Nanotechnology Based Diagnostics and Treatment Methods Pose Challenges
  • Nanomaterials Use: Weighed Down with Toxicity Concerns
  • Production Issues Continue to Plague Nanobiotech Industry
  • Lack of De Facto Standards: A Challenge to Reckon With
  • Embroilment over Ethical Issues
  • Social Relevance
  • Economic Relevance

5. INDUSTRY STRUCTURE

  • Industry Structure: A Quick Primer
  • A Peek into the Regulatory Framework
  • United States
  • Europe
  • A Closer Look at Regional Nano Efforts
  • United States: Unraveling the Country's Edge
    • Table 3: Nanotechnology Patents in United States Patent and Trademark Office by Leading Countries: 2014-2016 (Sep) (includes corresponding Graph/Chart)
    • Table 4: Nanotechnology Patents In European Patent Office by Leading Countries: 2014-2016 (Sep) (includes corresponding Graph/Chart)
    • Table 5: Leading Countries in Terms of Number of Research Publications for Nanopolymeric Cardiac Scaffolds: 2005-2015 (June) (includes corresponding Graph/Chart)
  • Europe: Hot on the Heels of the US
    • Germany
    • France
    • United Kingdom
    • Scandinavia
  • Japan: A Noteworthy Region

6. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE

  • A Primer
  • Impact on Drug Delivery Systems
  • Benefits Offered
    • Drug Encapsulation
    • High Level of Specificity
    • Increase in Drug Solubility and Uptake
    • Greater Usage Flexibility
  • Impact on Molecular Diagnostic Imaging
  • Seeing the Unseen
  • Impact on Therapeutics
  • Silver Nanoparticles as Effective Antimicrobial Agents
  • Modern Day Nanomedicine: A Current Scenario
  • Nanomedicine: The Cynosure of All Eyes
    • Applications of Nanomedicine
      • Drug Delivery
      • Drugs/ Therapy
      • In Vivo Imaging
      • In Vitro Diagnostics
      • Biomaterials
      • Active Implants
    • Drug Delivery Systems Epitomized by Nanomedicine
      • Targeted NanoDrug Delivery & Release
      • Active and Passive Targeting Mechanisms in Drug Delivery
      • Sustained and Pulsatile Release Mechanisms in Drug Delivery
      • A Peek into Potential Nanobio Enabled Drug Carriers
      • Micelles
      • Liposomes
      • Dendrimers & Liquid Crystals
      • Nanoparticles
      • Polymeric Nanoparticles
      • Hydrogels
      • Molecularly Imprinted Polymers
      • Microelectromechanical Systems (MEMS)
      • Nanosuspensions
      • Fullerenes: A Platform for GenX Drug Delivery
      • Types of Nano-Based Drug Delivery Systems, Related Materials, and Structures
      • Dynamics of Regenerative Medicine
    • Tissue Engineering and Restorations
  • Nanotechnology Enabled Diagnostics
    • Promised Path Breaking Applications in Molecular Diagnostics & Imaging
      • In-Vitro Diagnostics
      • Nanoprobes & Implantable Devices in In-vivo Imaging
      • Nanocomposites in Molecular Labeling & Diagnostics
      • Laboratory-on-a-Chip - A Revolutionary Technology in Biomolecular Detection
      • Biosensors - Heralding New Opportunities in Molecular Diagnostics
      • Nanobiosensors - A New Approach to Diagnostics Testing
      • Despite Huge Potential ... Key Hurdles Remain in Commercialization
      • Magnetic Nanoparticles for Imaging Applications in MRI
      • Dendrimers Promise Milestone Applications in MRI
  • Conclusions
  • Gauging the Real World Impact of Nanobiotech on Cancer: A Case Study
  • Quantum Dots Cock a Snook at Traditional Anti-Body Labeling Agents
  • Chemotherapeutic Reengineering & Gene Therapy: New Treatment Regimes
  • Futuristic Applications
  • Bio-molecular Motors
  • Genetic and Tissue Engineering
    • External Tissue Products
    • Internal Tissue Implants
    • Dental and Bone Replacement
    • Protein and Gene Analysis
    • Nanorobot Therapeutics
  • Laboratory-on-chip (LOC): A Portable Diagnostic Laboratory
    • Organs-On-A-Chip: Mimics Physiological Activities of Human Organs
  • Medical Diagnostic Sensors
  • Nano Medical Devices - From Surgical Tools to Contact Lenses
  • Nanoengineered Prosthetics
  • Nanotubes - Potential Drug Delivery Vehicles

7. INNOVATIONS & ADVANCEMENTS

  • A*STAR Researchers Develop Nano-Sized Drug Molecules for Cancer Treatment
  • MIT Researchers Develop Nanodevice for Fighting Against Cancer Drug Resistance
  • Gold Nanotubes for Several Applications in the Fight Against Cancer
  • IBM Research Working on NanoDLD Technology for Early Diagnosis of Cancer and other Diseases
  • Antifungal Bionanocomposites for Medical Devices
  • DNA Nanostructures for Smart Diagnosis and Drug Delivery
  • Japanese Scientists Develop CNTs with Polymeric Coatings for Enhanced Drug Delivery
  • Other Noteworthy Nanotechnology Related Technology Innovations

8. CONCEPTUAL OVERVIEW

  • Nanotechnology: An Introduction
  • A Revolution in the Making
  • Nanobiotechnology: An Exposition
  • Nanobiotechnology & Medicine
  • Nanobiotechnology & Biofuels
  • Analysis of Major Technology Segments
  • Nanomaterials
    • Nanoparticles
      • Nanoparticles in Labeling or Bio Tagging
      • Nanoparticles as Biomarkers
      • Classification of Nanoparticles
      • Solid Nanoparticles
      • Solid Lipid Nanoparticles
      • Calcium Phosphate Nanoparticles
      • Dendrimers
      • Cubosomes
    • Nanocomposites
      • Lamellar Nanocomposites
    • Nanostructured Materials and Membranes
    • Quantum Dots
    • Nanotubes and Fullerenes
      • Fullerenes
      • Nanotubes
      • Carbon Nanotubes (CNTs)
    • Other Nanomaterials
      • Nanoshells
      • Nanohorns
      • Nanocapsules
  • Nanodevices
  • Nanotools
    • Select Nanotools
      • Atomic Force Microscopes
      • Hot Embossing Lithography
      • Dip-Pen Nanolithography
  • Nanotechnology for Diseases Treatment
  • Cancer
  • Parkinson's Disease
  • Alzheimer's Disease
  • Tuberculosis
  • Dentistry
  • Ophthalmology
  • Surgery

9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS

  • Cornell's Nanobiotechnology Center (USA)
  • Institute of Bioengineering and Nanotechnology (Singapore)
  • Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) (USA)
  • The Tyndall National Institute (Ireland)

10. RECENT INDUSTRY ACTIVITY

  • Vectura Group Inks Merger Agreement with Skyepharma
  • Flamel Technologies to Merge with Avadel Pharmaceuticals
  • Pfizer to Acquire BIND Therapeutics Assets
  • Janssen Sciences Ireland Enters into Collaboration with ViiV Healthcare
  • Tekna Holdings Canada Inks Agreement with National Research Council of Canada
  • Roche and BioMed X Sign a Collaboration Agreement
  • Ablynx Enters into Exclusive Research Collaboration with Genzyme
  • Pfizer Exercises Option to Develop and Commercialize Accurin
  • BIND Therapeutics Inks Joint Research and Development Agreement with Merck

11. FOCUS ON SELECT GLOBAL PLAYERS

  • Ablynx NV (Belgium)
  • Arrowhead Pharmaceuticals, Inc. (USA)
  • Avadel Pharmaceuticals plc (Ireland)
  • CaPtivate Pharmaceuticals LLC (USA)
  • Celgene Corporation (USA)
  • ELITechGroup (France)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson (USA)
  • Merck & Co., Inc. (USA)
  • NanoBio(r) Corporation (USA)
  • Nanophase Technologies Corporation (USA)
  • pSivida Corp. (USA)
  • Sigma-Aldrich Corp. (USA)
  • Starpharma Holdings Ltd. (Australia)
  • Vectura Group plc (UK)

12. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 8: World 14-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Industry Overview
    • Academic Research Lending Strength to Creation of Novel Nanobiotech Products
    • Table 9: Number of Drugs Approved by FDA: 2001-2016 (includes corresponding Graph/Chart)
    • Public Sector Funding
    • Table 10: National Nanotechnology Initiative Budget in US$ Million by Agency (2015-2017) (includes corresponding Graph/Chart)
    • Connecticut - A Key Region with Focus on Nanomedicine
    • Patent Activity in Nanomedicine Domain
    • Major Nanobiotechnology Institutions and Centers
      • The Nanobiotechnology Center (NBTC)
      • Key Technological Advances Achieved by NBTC
      • Principal NBTC Partners
      • Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS)
      • Centers of Cancer Nanotechnology Excellence (CCNEs)
    • Regulatory Environment
      • FDA's Regulatory Approach to Nanotechnology Products
      • The Perils of Current Regulatory Status on Nanostructures
      • Few Challenges Faced by FDA
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: US Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 12: US Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. JAPAN

  • A. Market Analysis
    • Outlook
    • Table 13: R&D Expenditure in Japan (2015): Percentage Breakdown of Expenditure by Industrial Sector for Energy, Environmental S&T, ICTs, Life sciences, Materials, Nanotechnology, and Others (includes corresponding Graph/Chart)
    • Nanomedicines in Japan - An Overview
      • List of Select Nanomedicines Approved in Japan
      • Regulations on Nanomedicine in Japan
  • B. Market Analytics
    • Table 14: Japanese Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: Japanese Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • The Rise of Nanobiotechnology in Europe
    • EU Gears Up for Clarity on Nanomedicine Regulations
    • Market Overview
      • Nano2Life Network
    • Public Sector Funding
    • Regulatory Environment
      • Registration for Novel Nanobiotech Drugs Pose Major Bottlenecks
    • A Snapshot of Nanotherapeutic Products in the EU
      • List of Select Oral Nanotherapeutic Products
      • List of Select Nanotherapeutic Products for Parenteral Administration
      • List of Select Nanotherapeutic Products for Parenteral Administration in the EU
    • Focus on Select Markets
      • Germany
      • A Regional Hub for Nanomedicine Research
      • France
      • Nanotechnology and Nanomedicine - An Overview
      • Regulations on Nanomaterials
      • United Kingdom
      • UK Bets on Advancing Nanotechnology
      • Russia
      • Russian Biotech Players Eye Partnerships with Indian Counterparts
      • Rest of Europe
      • Ireland
      • Market Overview
      • Key Research Institutions/Centers in Nanobiotechnology
      • The Tyndall National Institute
      • The Centre for Research on Adaptive Nanostructures and NanoDevices
      • The National Centre for Sensor Research
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 16: European Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 17: European Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. REST OF WORLD

  • A. Market Analysis
    • Public Sector Funding
    • Focus on Select Markets
      • Australia
      • Market Overview
      • Major Institutions
      • Commonwealth Scientific and Industrial Research Organisation (CSIRO)
      • China
      • New Findings Reinforce Role of Silica Nanoparticles in Drug Delivery and Diagnostics
      • Nanotechnology Patent Profile in China
      • India
      • Market Overview
      • Nanotechnology to Spur Indian Pharmaceutical Industry
      • Government Takes Big Initiatives to Promote Nanobiotechnology
      • Agriculture, Livestock Sectors to Warm Up to Nanobiotechnology Benefits
      • South Korea
      • Taiwan
      • Nanotechnology in Medicine - Small Yet Growing Segment in Taiwan
      • Iran
    • Strategic Corporate Development
    • Starpharma Holdings Ltd. - A Major Australian Player
  • B. Market Analytics
    • Table 18: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 19: Rest of World Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top